Guru P. Sonpavde, MD

Phase I+GU Oncology Director @AdventHealthCFL #Cancer Institute, Prof. @ucf Orlando, #Florida, #ASCO, #ESMO, #AACR, Following/Retweet ≠ endorsement, Views mine

[OncoNexus @Onco_Nexus]

What does a biomarker driven approach look like in MIBC? In this clip, @UroDocAsh shares his insights on newer strategies like utDNA surveillance and its need to prove clear value alongside established tools like FISH and ctDNA.

Full Discussion:
https://t.co/vZ3rVCSRMw

@siadaneshmand
@MattGalsky
@sonpavde
@BradMcG04
@PGrivasMDPhD

[Guru P. Sonpavde, MD @sonpavde]

Please note @HemOncFellows

[Guru P. Sonpavde, MD @sonpavde]

We are #Hiring at @AdventHealthCFL #cancer Institute, Orlando, #Florida area! Looking for Genitourinary (GU) #cancer-focused medical Hematologist-Oncologist to also support the rapidly growing Phase I solid tumor #clinicaltrial program- especially suitable for a junior medical oncologist who is interested in a hybrid of #prostatecancer focused medical oncology practice + clinical trials (#research) and wants to develop an #earlydrugdevelopment career- and an opportunity to collaborate with world class urology and Radiation Oncology team - flexibly tailor the practice to fit career goals - @AdventHealthCFL was ranked as one of the top 20 hospitals by US News & World Report in 2025-and the among the top 50 in the nation for 6 medical specialties including #Cancer - we are the largest healthcare system in central Florida - and a teaching program with Internal Medicine residency - and will have a Hematology-Oncology fellowship in the near future
https://t.co/eQiJYIymJ3

[OncLive.com @OncLive]

Moving the needle in MIBC: From novel neoadjuvant therapies to Signatera assay integration. Dive into our latest 12-episode series featuring top oncology experts as they discuss personalizing treatment and improving patient communication through ctDNA.

Stream here: https://t.co/AmOhKTP6Se

@tompowles1 @QMBCI @alantanmd @VUmedicine @sonpavde
@AdventHealthCFL @PGrivasMDPhD @fredhutch @OncoBellmunt
@DanaFarber_GU

[Guru P. Sonpavde, MD @sonpavde]

#PenileCancer update at #MaTOSGU2026 - Pleased to attend and discuss from @Adventhealth #Cancer Institute @AdventHealthCFL, Orlando, #Florida - Global collaboration is critically important to accelerate advances #GSRGT (Global Society of Rare GU Tumors) @AndreaNecchi @SpiessPhilippe @JadChahoud @apolo_andrea - thanks to organizers @PGrivasMDPhD @LuisERaez1 @mecmededucation

[Sia Daneshmand, M.D. @siadaneshmand]

Really enjoyed this session with colleagues ⁦@UroDocAsh⁩ @BradMcG04 @mattgalsky ⁦@sonpavde led by ⁦@PGrivasMDPhD⁩ What’s Next in Bladder Cancer Treatment? - https://t.co/gx9WfvYcMH https://t.co/GYVRQ9wM3c

[Arnab Basu @arnabguonc]

Enjoyed debating #Joshlinscott of @MoffittNews on bladder sparing after CCR - not primetime yet but #utDNA and #ctDNA will be 🔑! Studies Coming soon!

@sonpavde @shilpaonc @koshkin85 @alantanmd @OncoAlert @ZakhariaYousef @Parminder1699 @tompowles1

[OLN Great Debates in Solid Tumors @OLNGreatDebates]

The debates are concluded but the conversations are still going!

Thanks to the faculty and clinicians who made OLN Great Debates in Solid Tumors in Miami a thoughtful, practical exchange on real decision points in solid tumor care.

New York is next!
Sept 26–27
https://t.co/f4oT2L46h2

#OLNGreatDebates #Oncology @Latinamd @KelseyPanMD @arnabguonc @sonpavde

[Sia Daneshmand, M.D. @siadaneshmand]

It was a pleasure to discuss the latest findings that bring new treatments to our patients #GU26. Honor to be among these amazing leaders led by the charismatic and visionary leader @PGrivasMDPhD along with @UroDocAsh, @oncologydoc @sonpavde, Brad McGregor MD. #bladdercancer #clinicaltrials @BladderCancerUS @IBCG_BladderCA @ASCO @ASCOPost

[Guru P. Sonpavde, MD @sonpavde]

Pleased to have mentored @rohitjainMD on this #clinicaltrial combining EV plus pan -FGFR inhibiting targeted agent Erdafitinib for advanced #bladdercancer #urothelialcarcinoma

[Dr. Bishoy M. Faltas @FaltasLab]

Congratulations to my colleague @rohitjainMD on this important IIT of FGFR3i + EV in metastatic urothelial cancer #BladderCancer #GU26 @WCMGUcancer

[Dr. Bishoy M. Faltas @FaltasLab]

Congratulations to my colleague @rohitjainMD on this important IIT of FGFR3i + EV in metastatic urothelial cancer #BladderCancer #GU26 @WCMGUcancer

[OncoNexus @Onco_Nexus]

Live from ASCO GU: Key leaders in bladder cancer are diving into the data shaping practice today.

@PGrivasMDPhD
@UroDocAsh
@sonpavde
@siadaneshmand
@MattGalsky
@BradMcG04

[CURE Today @cure_today]

There is still time to check out our preview to ASCO #GU26 biggest updates!

Learn more from the leading experts ahead of the meeting today! @sonpavde @AdventHealthCFL @CParkMD @Norton_Health @yekeduz_emre @DanaFarber @MikeSerzanMD

🔗 Read more: https://t.co/77hFb0Jkzz

[OncoAlert @OncoAlert]

Dear Colleaguest at #GU26
WELCOME TO San Francisco
We Are All @OncoAlert 🚨

@montypal @crisbergerot @DrDanielHeng @apolo_andrea @DrChoueiri @PGrivasMDPhD @TiansterZhang @HHammersMD @ravikanesvaran @neerajaiims @amerseburger @sonpavde @drenriquegrande @scserendipity1 @Silke_Gillessen
@EfstathiouEleni @tompowles1 @BraunMDPhD @nataliagandur @cdanicas @brian_rini @AOmlin

#OncoAlertAF
@nataliagandur @acampsmalea @BRicciutiMD @HHorinouchi @FadiHaddad_MD @Abdallah81MD @FernandoOnco @ElisaAgostinett @to_be_elizabeth @bavilima @realbowtiedoc @Erman_Akkus @Lucarecco @GaiaGriguolo @JankovicK
@MarioBalsaMD @DrMirallas @GIMedOnc @OscarTahuahua @UOzkerim @DrRishabhOnco @Onco_Cifu88 @PaulJiL @DaisukeKotani @DraMartinezLago

[OLN Great Debates in Solid Tumors @OLNGreatDebates]

Florida is showing up in a big way for #OLNGreatDebates this March in Miami!

We’re proud to welcome an exceptional group of faculty from across the state, representing @MoffittNews, @SylvesterCancer, @MayoClinic, Memorial Cancer Institute, @AdventHealth, @MountSinaiMiami, @OncologyInst, and @MiamiCancerInst.

Take a look at their debates: https://t.co/QsipAUJckd

#Oncology #MedicalOncology #GICancer #LungCancer #BreastCancer #GUCancer #GynecologicOncology

[Emre Yekedüz @yekeduz_emre]

What's waiting for our patients at @ASCO #GU26 ? Just before heading to San Francisco discussed and shared insights in @cure_today ! @sonpavde @MikeSerzanMD @CParkMD #Cancer #oncology #kidneycancer #prostatecancer #bladdercancer @OncLive

https://t.co/hnFHchZ8wj